Corify Care today announced that the U.S. Food and Drug Administration (FDA) has granted clearance for the ACORYS® System, ...

Corify Care announced today that it received FDA clearance for its Acorys imageless, non-invasive cardiac mapping platform.

Prominent European electrophysiology labs and hospitals have embraced the next generation mapping system’s automation, flexibility and precision for tailoring treatment for patients with cardiac ...

New FARAWAVE™ NAV Ablation Catheter and FARAVIEW™ Software combine with OPAL HDx™ Mapping System to provide visualization during pulsed field ablation Today, physicians may utilize a separate mapping ...

Figuring out what is causing an irregular heartbeat typically means an invasive procedure: most often, electrophysiologists insert a catheter to the heart via an artery or vein to get a cardiac “map” ...

Dublin, Jan. 23, 2020 (GLOBE NEWSWIRE) -- The "Cardiac Mapping Market by Product (Contact Mapping Systems (Electroanatomical Mapping, Basket Catheter Mapping), Non-contact Mapping Systems), Indication ...

(RTTNews) - Boston Scientific Corp. (BSX) said it has received U.S. Food and Drug Administration approval for the navigation-enabled FARAWAVE NAV Ablation Catheter for the treatment of paroxysmal ...

Enrollment completed ahead of schedule in the global IDE for Abbott (ABT)'s Volt™ PFA System Global FOCALFLEX trial now underway for Abbott's TactiFlex™ Duo Ablation Catheter, Sensor Enabled™ Advisor™ ...

According to Emergen Research, the cardiac mapping market is expected to reach a significant value of USD 4.83 billion by 2032. The market's growth can be attributed to advancements in cardiac ...